J
Jason Dehn
Researcher at National Marrow Donor Program
Publications - 39
Citations - 1475
Jason Dehn is an academic researcher from National Marrow Donor Program. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 17, co-authored 39 publications receiving 1157 citations.
Papers
More filters
Journal ArticleDOI
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation
Joseph Pidala,Stephanie J. Lee,Kwang Woo Ahn,Stephen R. Spellman,Hai-Lin Wang,Mahmoud Aljurf,Medhat Askar,Jason Dehn,Marcelo A. Fernandez Viña,Alois Gratwohl,Vikas Gupta,Rabi Hanna,Mary M. Horowitz,Carolyn Katovich Hurley,Yoshihiro Inamoto,Adetola A. Kassim,Taiga Nishihori,Carlheinz Mueller,Machteld Oudshoorn,Effie W. Petersdorf,Vinod K. Prasad,James Robinson,James Robinson,Wael Saber,Kirk R. Schultz,Bronwen E. Shaw,Bronwen E. Shaw,Jan Storek,William A. Wood,Ann E. Woolfrey,Claudio Anasetti +30 more
TL;DR: Current outcomes of unrelated donor allogeneic hematopoietic cell transplantation (HCT) is examined to determine the clinical implications of donor-recipient HLA matching, and full matching at HLA-A, -B, -C, and -DRB1 is required for optimal unrelated donor HCT survival.
Journal ArticleDOI
Prevalence of hematopoietic cell transplant survivors in the United States.
Navneet S. Majhail,Navneet S. Majhail,Li Tao,Christopher Bredeson,Stella M. Davies,Jason Dehn,James Gajewski,Theresa Hahn,Ann A. Jakubowski,Steven Joffe,Hillard M. Lazarus,Susan K. Parsons,Kim Robien,Stephanie J. Lee,Karen M. Kuntz +14 more
TL;DR: Transplant center providers, hematologists, oncologists, primary care physicians, and other specialty providers will need to be familiar with the unique and complex health issues faced by this population of HCT survivors.
Journal ArticleDOI
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
Jason Dehn,Stephen R. Spellman,Carolyn Katovich Hurley,Bronwen E. Shaw,Juliet N. Barker,Juliet N. Barker,Linda J. Burns,Linda J. Burns,Dennis L. Confer,Dennis L. Confer,Mary Eapen,Marcelo Fernandez-Vina,Robert J. Hartzman,Martin Maiers,Susana R. Marino,Carlheinz Mueller,Miguel-Angel Perales,Miguel-Angel Perales,Raja Rajalingam,Joseph Pidala +19 more
TL;DR: The National Marrow Donor Program and the Center for International Blood and Marrow Transplant Research, jointly with the NMDP Histocompatibility Advisory Group, provide evidence-based guidelines for optimal selection of unrelated donors and cord blood units.
Journal ArticleDOI
Race and Socioeconomic Status Influence Outcomes of Unrelated Donor Hematopoietic Cell Transplantation
K. Scott Baker,Stella M. Davies,Navneet S. Majhail,Navneet S. Majhail,Anna Hassebroek,John P. Klein,Karen K. Ballen,Carolyn Bigelow,Haydar Frangoul,Cheryl L. Hardy,Christopher Bredeson,Jason Dehn,Debra L. Friedman,Theresa Hahn,Gregory A. Hale,Hillard M. Lazarus,Charles F. LeMaistre,Fausto R. Loberiza,Dipnarine Maharaj,Philip L. McCarthy,Michelle Setterholm,Stephen R. Spellman,Michael E. Trigg,Richard T. Maziarz,Galen E. Switzer,Stephanie J. Lee,J. Douglas Rizzo +26 more
TL;DR: Low SES, regardless of race, has a negative impact on unrelated donor HCT outcomes and inferior outcomes among African Americans are not fully explained by transplant-related factors or SES.
Journal ArticleDOI
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders.
John T. Horan,Tao Wang,Michael Haagenson,Stephen R. Spellman,Jason Dehn,Mary Eapen,Haydar Frangoul,Vikas Gupta,Gregory A. Hale,Carolyn Katovich Hurley,Susana R. Marino,Machteld Oudshoorn,Vijay Reddy,Peter J. Shaw,Stephanie J. Lee,Ann E. Woolfrey +15 more
TL;DR: Patients with NMD should receive transplants from allele matched (8/8) donors if possible, and HLA mismatches in NMD is associated with graft failure rather than GVHD.